Quo vadis reactive arthritis?
Journal
Current opinion in rheumatology
ISSN: 1531-6963
Titre abrégé: Curr Opin Rheumatol
Pays: United States
ID NLM: 9000851
Informations de publication
Date de publication:
01 07 2022
01 07 2022
Historique:
pubmed:
15
6
2022
medline:
30
6
2022
entrez:
14
6
2022
Statut:
ppublish
Résumé
We provide an overview of recent articles which describe new thinking regarding HLA-B27-associated reactive arthritis (ReA), including those additional infection-related arthritides triggered by microbes that often are grouped under the term ReA. With the advent and continuation of the pandemic, an increasing number of cases and case series of post-COVID-19 arthritis have been reported and classified as ReA. Further, arthritis after COVID-19 vaccination is a new entity included within the spectrum of ReA. New causative microorganisms identified in case reports include Clostridium difficile, Mycoplasma pneumoniae, Giardia lamblia, Leptospira , and babesiosis. SARS-CoV-2 is emerging as a significant etiologic agent for apparent ReA. It is now clear that comprehensive clinical and laboratory investigations, synovial fluid analyses, and close follow-up of patients all are essential to differentiate ReA from diseases that may present with similar clinical attributes. Further, and importantly, additional research is required to define the wide diversity in causative agents, epidemiology, and rare case presentations of these arthritides. Finally, new classification and diagnostic criteria, and updated treatment recommendations, are essential to the advancement of our understanding of ReA.
Identifiants
pubmed: 35699331
doi: 10.1097/BOR.0000000000000880
pii: 00002281-202207000-00006
doi:
Substances chimiques
COVID-19 Vaccines
0
HLA-B27 Antigen
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
218-224Informations de copyright
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Références
Toivanen A, Toivanen P. Reactive arthritis. Curr Opin Rheumatol 2000; 12:300–305.
Carter JD, Hudson AP. The evolving story of Chlamydia-induced reactive arthritis. Curr Opin Rheumatol 2010; 22:424–430.
van der Helm-van M, Annette HM. Acute rheumatic fever and poststreptococcal reactive arthritis reconsidered. Curr Opin Rheumatol 2010; 22:437–442.
Kononoff A, Arstila L, Pussinen P, et al. Incidence of inflammatory joint diseases in Finland: results from a population-based epidemiological study. Rheumatol Int 2017; 37:1693–1700.
Bentaleb I, Abdelghani KB, Rostom S, et al. Reactive arthritis: update. Curr Clin Microbiol Rep 2020; 1–9.
Alamanos Y, Pelechas E, Voulgari PV, Drosos AA. Incidence of spondyloarthritis and its subtypes: a systematic review. Clin Exp Rheumatol 2021; 39:660–667.
Pogreba-Brown K, Austhof E, Tang X, et al. Enteric pathogens and reactive arthritis: systematic review and meta-analyses of pathogen-associated reactive arthritis. Foodborne Pathog Dis 2021; 18:627–639.
Borud EK, Håberg SE, Norheim AJ, et al. Yersinia enterocolitica: a follow-up of the outbreak in the Norwegian Armed Forces in 2014. Mil Med 2021; 186:e996–e1000.
Tuompo R, Lääveri T, Hannu T, et al. Reactive arthritis and other musculoskeletal symptoms associated with acquisition of diarrhoeagenic Escherichia coli . Ann Rheum Dis 2020; 79:605–611.
Denison HJ, Curtis EM, Clynes MA, et al. The incidence of sexually acquired reactive arthritis: a systematic literature review. Clin Rheumatol 2016; 35:2639–2648.
Zeidler H, Hudson AP. Chlamydia -induced reactive arthritis: disappearing entity or lack of research? Curr Rheumatol Rep 2019; 21:63.
Zeidler H, Hudson AP. Reactive arthritis update: spotlight on new and rare infectious agents implicated as pathogens. Curr Rheumatol Rep 2021; 23:53.
Brinster A, Guillot X, Prati C, Wendling D. Evolution over thirty years of the profile of inpatients with reactive arthritis in a tertiary rheumatology unit. Reumatol Clin 2018; 14:36–39.
Danssaert Z, Raum G, Hemtasilpa S. Reactive arthritis in a 37-year-old female with SARS-CoV2 infection. Cureus 2020; 12:e9698.
Liew IY, Mak TM, Cui L, et al. A case of reactive arthritis secondary to coronavirus disease infection. J Clin Rheumatol 2020; 26:233.
García-Kutzbach A, Chacón-Súchite J, García-Ferrer H, Iraheta I. Reactive arthritis: update 2018. Clin Rheumatol 2018; 37:869–874.
Carter JD, Hudson AP. Recent advances and future directions in understanding and treating Chlamydia-induced reactive arthritis. Expert Rev Clin Immunol 2017; 13:197–206.
Schmitt SK. Reactive arthritis. Infect Dis Clin N Am 2017; 31:265–1075.
Gérard HC, Wang Z, Wang GF, et al. Chromosomal DNA from a variety of bacterial species is present in synovial tissue in patients with various forms of arthritis. Arthritis Rheum 2001; 44:1689–1697.
Mousave S, Bereswill S, Heimesaat MM. Novel clinical Campylobacter jejuni infection models based on sensitization of mice to lipooligosaccharide, a major bacterial factor triggering innate immune responses in human campylobacteriosis. Microorganisms 2020; 8:482.
Rosenbaum JT, Asquith M. The microbiome and HLA-B27-associated acute anterior uveitis. Nat Rev Rheumatol 2018; 14:704–713.
Manasson J, Shen N, Garcia Ferrer HR, et al. Gut microbiota perturbations in reactive arthritis and postinfectious spondyloarthritis. Arthritis Rheumatol 2018; 70:242–254.
Verma A, Sharda S, Rathi B, et al. Elucidating potential molecular signatures through host-microbe interactions for reactive arthritis and inflammatory bowel disease using combinatorial approach. Sci Rep 2020; 10:15131.
Mărginean CO, Georgescu AM, Meliţ LE. Arthritis associated with Mycoplasma pneumoniae in a pediatric patient: a case report. Medicine (Baltimore) 2021; 100:e24316.
Reinholz A, Mannuru D, Bande D, Matta A. Reactive arthritis: an unusual presentation of acute Clostridioides difficile colitis. BMJ Case Rep 2021; 14:e240890.
Harjacek M, Ostojic J, Djakovic RO. Juvenile spondyloarthropathies associated with Mycoplasma pneumoniae infection. Clin Rheumatol 2006; 25:470–475.
Pilianidis G, Tsinari A, Pandis D, et al. Chronic seronegative spondyloarthropathy following acute Mycoplasma pneumoniae infection in a human leukocyte antigen B27-positive patient: a case report. J Med Case Rep 2020; 14:155.
Dey S, Sipani AK, Das R. Case report of a rare cause of reactive arthritis: leptospirosis. J Orthop Case Rep 2021; 11:79–84.
Strizova Z, Havlova K, Patek O, et al. The first human case of babesiosis mimicking Reiter's syndrome. Folia Parasitol (Praha) 2020; 67:031.
Kobayashi S, Taniguchi Y, Kida I, Tamura N. SARS-CoV2-triggered acute arthritis: viral arthritis rather than reactive arthritis. J Med Virol 2021; 93:6458–6459.
Ahmed S, Zimba O, Gasparyan AY. COVID-19 and the clinical course of rheumatic manifestations. Clin Rheumatol 2021; 40:2611–2619.
Zeidler H. Post-COVID-19-arthritis. Manifestation unter dem klinischen Bild einer reaktiven Arthritis [Post-corona-virus-disease-19 arthritis. Manifestation under the clinical picture of a reactive arthritis]. Z Rheumatol 2021; 80:555–558. German.
Gasparotto M, Framba V, Piovella C, et al. Post-COVID-19 arthritis: a case report and literature review. Clin Rheumatol 2021; 40:3357–3362.
Wendling D, Verhoeven F, Chouk M, Prati C. Can SARS-CoV-2 trigger reactive arthritis? Joint Bone Spine 2021; 88:105086.
Colatutto D, Sonaglia A, Zabotti A, et al. Post-COVID-19 arthritis and sacroiliitis: natural history with longitudinal magnetic resonance imaging study in two cases and review of the literature. Viruses 2021; 13:1558.
Kocyigit BF, Akyol A. Reactive arthritis after COVID-19: a case-based review. Rheumatol Int 2021; 41:2031–2039.
Santacruz JC, Londoño J, Santos AM, et al. Extra-articular manifestations in reactive arthritis due to COVID-19. Cureus 2021; 13:e18620.
Carlin E, Marzo-Ortega H, Flew S. British Association of Sexual Health and HIV national guideline on the management of sexually acquired reactive arthritis 2021. Int J STD AIDS 2021; 32:986–997.
Jubber A, Moorthy A. Reactive arthritis: a clinical review. J R Coll Physicians Edinb 2021; 51:288–297.
Taniguchi Y, Nishikawa H, Yoshida T, et al. Expanding the spectrum of reactive arthritis (ReA): classic ReA and infection-related arthritis including poststreptococcal ReA, Poncet's disease, and iBCG-induced ReA. Rheumatol Int 2021; 41:1387–1398.
Carter JD, Espinoza LR, Inman RD, et al. Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis: a double-blind, placebo-controlled, prospective trial. Arthritis Rheum 2010; 62:1298–1307.
Jaladhar P, Chandrashekara S, Salanke M, Kori D. The pattern of postviral arthritis in COVID pandemic state: an experience of tertiary care centre. J Assoc Physicians India 2021; 69:47–50.